GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » eFFECTOR Therapeutics Inc (FRA:LWK) » Definitions » Institutional Ownership

eFFECTOR Therapeutics (FRA:LWK) Institutional Ownership : 5.90% (As of Sep. 21, 2024)


View and export this data going back to 2021. Start your Free Trial

What is eFFECTOR Therapeutics Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, eFFECTOR Therapeutics's institutional ownership is 5.90%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, eFFECTOR Therapeutics's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, eFFECTOR Therapeutics's Float Percentage Of Total Shares Outstanding is 99.16%.


eFFECTOR Therapeutics Institutional Ownership Historical Data

The historical data trend for eFFECTOR Therapeutics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

eFFECTOR Therapeutics Institutional Ownership Chart

eFFECTOR Therapeutics Historical Data

The historical data trend for eFFECTOR Therapeutics can be seen below:

2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31 2024-06-30
Institutional Ownership 1.99 1.48 1.61 2.07 3.95 3.75 4.37 6.05 5.90 5.90

eFFECTOR Therapeutics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


eFFECTOR Therapeutics Business Description

Traded in Other Exchanges
Address
142 North Cedros Avenue, Suite B, Solana Beach, CA, USA, 92075
eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as selective translation regulator inhibitors (STRIs).

eFFECTOR Therapeutics Headlines

No Headlines